article

Drug Target Review – Issue 1 2022

In this issue are articles on the development of mRNA vaccines against latent viruses, how memory B cell antibody-based treatments can help to fight cancer and the potential of AI in drug discovery. Also included are pieces on biotherapeutics, immuno-oncology and assays. 

Included in this issue:

  • CELL LINE DEVELOPMENT
    The growth of cell line development
    Victoria Rees, Drug Target Review
  • LAB AUTOMATION
    Enhancing confocal microscopy with AI
    Dr Hari Shroff, US National Institutes of Health (NIH)
  • ANTIBODIES
    Neutralising SARS-CoV-2 with intranasally-delivered antibodies
    Dr Chris Takimoto, IGM Biosciences
  • IMMUNO-ONCOLOGY
    How to develop the next generation of CAR T-cell therapies
    Dr Sarwish Rafiq, Emory University
  • VACCINE DEVELOPMENT
    Are scientists closing in on vaccines for Alzheimer’s and Parkinson’s?
    Dr Andrea Pfeifer, AC Immune
  • ASSAYS
    Driving precision neurology forwards with iPSCs and new assays
    Dr Evangelos Kiskinis, Northwestern University